Pozios, I., Seel, N. N., Hering, N. A., Hartmann, L., Liu, V., Camaj, P., . . . Seeliger, H. (2021). Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. Cellular Oncology, 44(1), 167. https://doi.org/10.1007/s13402-020-00559-9
Chicago-referens (17:e uppl.)Pozios, Ioannis, et al. "Raloxifene Inhibits Pancreatic Adenocarcinoma Growth by Interfering with ERβ and IL-6/gp130/STAT3 Signaling." Cellular Oncology 44, no. 1 (2021): 167. https://doi.org/10.1007/s13402-020-00559-9.
MLA-referens (9:e uppl.)Pozios, Ioannis, et al. "Raloxifene Inhibits Pancreatic Adenocarcinoma Growth by Interfering with ERβ and IL-6/gp130/STAT3 Signaling." Cellular Oncology, vol. 44, no. 1, 2021, p. 167, https://doi.org/10.1007/s13402-020-00559-9.
